Clinical Trials

Pancreatic Cancer Liver Metastases

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

30 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

28 enrolled

Small Cell Lung Carcinoma

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

36 enrolled

Phase 1/2 Not yet recruiting

Unresectable Non-small Cell Lung Cancer

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

33 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

44 enrolled

Recurrence

NCT06449937 2024-06-10

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Phase NA Recruiting

130 enrolled

Colorectal Neoplasms

NCT05599698 2024-05-14

Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

Phase NA Recruiting

38 enrolled

Tumor-Agnostic

Neoplasms

NCT06406608 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Phase NA Recruiting

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05490667 2023-10-30

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Phase NA Unknown

30 enrolled

Sarcoma

Desmoid Tumors

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

46 enrolled

Breast

HER2 Positive Metastatic Breast Cancer

NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Phase 2/3 Unknown

338 enrolled

Rectal Neoplasms

NCT02621333 2021-05-12

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Phase 2 Terminated

280 enrolled

Adenocarcinoma of Lung

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

70 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03985670 2019-12-12

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

30 enrolled

Classical hematologyLymphoid

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Phase 4 Unknown

120 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT03238261 2017-08-11

Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms

Phase NA Completed

147 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Phase 1/2 Unknown

16 enrolled

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT00864331 2013-08-07

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

Phase 3 Completed

251 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

315 enrolled

Adenocarcinoma, Lung Neoplasms

NCT00452803 2010-07-12

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

102 enrolled